Erich Mohr - Net Worth and Insider Trading

Erich Mohr Net Worth

The estimated net worth of Erich Mohr is at least $2 dollars as of 2024-09-20. Erich Mohr is the Director of Kintara Therapeutics Inc and owns about 12 shares of Kintara Therapeutics Inc (KTRA) stock worth over $2. Details can be seen in Erich Mohr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erich Mohr has not made any transactions after 2017-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Erich Mohr

To

Erich Mohr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erich Mohr owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and Eterna Therapeutics Inc (ERNA) .

Click here to see the complete history of Erich Mohr’s form 4 insider trades.

Insider Ownership Summary of Erich Mohr

Ticker Comapny Transaction Date Type of Owner
KTRA Kintara Therapeutics Inc 2017-12-31 director
ERNA Eterna Therapeutics Inc 2021-05-06 director

Erich Mohr Latest Holdings Summary

Erich Mohr currently owns a total of 1 stock. Erich Mohr owns 12 shares of Kintara Therapeutics Inc (KTRA) as of June 26, 2017, with a value of $2.

Latest Holdings of Erich Mohr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KTRA Kintara Therapeutics Inc 2017-06-26 12 0.18 2

Holding Weightings of Erich Mohr


Erich Mohr Form 4 Trading Tracker

According to the SEC Form 4 filings, Erich Mohr has made a total of 0 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 8 shares on June 26, 2017, which cost Erich Mohr around $15,001.

Insider Trading History of Erich Mohr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erich Mohr Trading Performance

GuruFocus tracks the stock performance after each of Erich Mohr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erich Mohr is -56.88%. GuruFocus also compares Erich Mohr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erich Mohr within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Erich Mohr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Erich Mohr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.26 LIMIT LIMIT LIMIT LIMIT LIMIT

Erich Mohr Ownership Network

Ownership Network List of Erich Mohr

No Data

Ownership Network Relation of Erich Mohr

Insider Network Chart

Erich Mohr Owned Company Details

What does Kintara Therapeutics Inc do?

Who are the key executives at Kintara Therapeutics Inc?

Erich Mohr is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .

Kintara Therapeutics Inc (KTRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kintara Therapeutics Inc Insider Transactions

No Available Data

Erich Mohr Mailing Address

Above is the net worth, insider trading, and ownership report for Erich Mohr. You might contact Erich Mohr via mailing address: 8300 Greensboro Drive, Mclean Va 22102.

Discussions on Erich Mohr

No discussions yet.